"Global Mosquito Borne Disease Market Overview:
Global Mosquito Borne Disease Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Mosquito Borne Disease Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Mosquito Borne Disease involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Mosquito Borne Disease Market:
The Mosquito Borne Disease Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Mosquito Borne Disease Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Mosquito Borne Disease Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Mosquito Borne Disease market has been segmented into:
Malaria
Dengue
Yellow Fever
West Nile Virus
Chikungunya
Zika Virus
and Others
By Application, Mosquito Borne Disease market has been segmented into:
Medication
Vaccination
Vector Control Methods
Immunotherapy
Supportive Care
and Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Mosquito Borne Disease market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Mosquito Borne Disease market.
Top Key Players Covered in Mosquito Borne Disease market are:
GlaxoSmithKline plc
Sanofi S.A.
Pfizer Inc.
Merck & Co. Inc.
Novartis AG
Johnson & Johnson
Eisai Co. Ltd
Takeda Pharmaceuticals
AstraZeneca
Valeant Pharmaceuticals
Mitsubishi Tanabe Pharma
Abbott
F. Hoffmann-La Roche Ltd
Sun Pharmaceutical Industries Ltd
Lupin Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc.
Mallinckrodt Pharmaceuticals
Serum Institute of India Pvt. Ltd.
CSL Limited
Teva Pharmaceutical Industries Ltd
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Mosquito Borne Disease Market by Type
4.1 Mosquito Borne Disease Market Snapshot and Growth Engine
4.2 Mosquito Borne Disease Market Overview
4.3 Malaria
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Malaria: Geographic Segmentation Analysis
4.4 Dengue
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Dengue: Geographic Segmentation Analysis
4.5 Yellow Fever
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Yellow Fever: Geographic Segmentation Analysis
4.6 West Nile Virus
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 West Nile Virus: Geographic Segmentation Analysis
4.7 Chikungunya
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Chikungunya: Geographic Segmentation Analysis
4.8 Zika Virus
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 Zika Virus: Geographic Segmentation Analysis
4.9 and Others
4.9.1 Introduction and Market Overview
4.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.9.3 Key Market Trends, Growth Factors and Opportunities
4.9.4 and Others: Geographic Segmentation Analysis
Chapter 5: Mosquito Borne Disease Market by Application
5.1 Mosquito Borne Disease Market Snapshot and Growth Engine
5.2 Mosquito Borne Disease Market Overview
5.3 Medication
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Medication: Geographic Segmentation Analysis
5.4 Vaccination
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Vaccination: Geographic Segmentation Analysis
5.5 Vector Control Methods
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Vector Control Methods: Geographic Segmentation Analysis
5.6 Immunotherapy
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Immunotherapy: Geographic Segmentation Analysis
5.7 Supportive Care
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Supportive Care: Geographic Segmentation Analysis
5.8 and Others
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 and Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Mosquito Borne Disease Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 GLAXOSMITHKLINE PLC
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 SANOFI S.A.
6.4 PFIZER INC.
6.5 MERCK & CO. INC.
6.6 NOVARTIS AG
6.7 JOHNSON & JOHNSON
6.8 EISAI CO. LTD
6.9 TAKEDA PHARMACEUTICALS
6.10 ASTRAZENECA
6.11 VALEANT PHARMACEUTICALS
6.12 MITSUBISHI TANABE PHARMA
6.13 ABBOTT
6.14 F. HOFFMANN-LA ROCHE LTD
6.15 SUN PHARMACEUTICAL INDUSTRIES LTD
6.16 LUPIN PHARMACEUTICALS INC.
6.17 BIOCRYST PHARMACEUTICALS INC.
6.18 MALLINCKRODT PHARMACEUTICALS
6.19 SERUM INSTITUTE OF INDIA PVT. LTD.
6.20 CSL LIMITED
6.21 TEVA PHARMACEUTICAL INDUSTRIES LTD
Chapter 7: Global Mosquito Borne Disease Market By Region
7.1 Overview
7.2. North America Mosquito Borne Disease Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Malaria
7.2.4.2 Dengue
7.2.4.3 Yellow Fever
7.2.4.4 West Nile Virus
7.2.4.5 Chikungunya
7.2.4.6 Zika Virus
7.2.4.7 and Others
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Medication
7.2.5.2 Vaccination
7.2.5.3 Vector Control Methods
7.2.5.4 Immunotherapy
7.2.5.5 Supportive Care
7.2.5.6 and Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Mosquito Borne Disease Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Malaria
7.3.4.2 Dengue
7.3.4.3 Yellow Fever
7.3.4.4 West Nile Virus
7.3.4.5 Chikungunya
7.3.4.6 Zika Virus
7.3.4.7 and Others
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Medication
7.3.5.2 Vaccination
7.3.5.3 Vector Control Methods
7.3.5.4 Immunotherapy
7.3.5.5 Supportive Care
7.3.5.6 and Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Mosquito Borne Disease Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Malaria
7.4.4.2 Dengue
7.4.4.3 Yellow Fever
7.4.4.4 West Nile Virus
7.4.4.5 Chikungunya
7.4.4.6 Zika Virus
7.4.4.7 and Others
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Medication
7.4.5.2 Vaccination
7.4.5.3 Vector Control Methods
7.4.5.4 Immunotherapy
7.4.5.5 Supportive Care
7.4.5.6 and Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Mosquito Borne Disease Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Malaria
7.5.4.2 Dengue
7.5.4.3 Yellow Fever
7.5.4.4 West Nile Virus
7.5.4.5 Chikungunya
7.5.4.6 Zika Virus
7.5.4.7 and Others
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Medication
7.5.5.2 Vaccination
7.5.5.3 Vector Control Methods
7.5.5.4 Immunotherapy
7.5.5.5 Supportive Care
7.5.5.6 and Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Mosquito Borne Disease Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Malaria
7.6.4.2 Dengue
7.6.4.3 Yellow Fever
7.6.4.4 West Nile Virus
7.6.4.5 Chikungunya
7.6.4.6 Zika Virus
7.6.4.7 and Others
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Medication
7.6.5.2 Vaccination
7.6.5.3 Vector Control Methods
7.6.5.4 Immunotherapy
7.6.5.5 Supportive Care
7.6.5.6 and Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Mosquito Borne Disease Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Malaria
7.7.4.2 Dengue
7.7.4.3 Yellow Fever
7.7.4.4 West Nile Virus
7.7.4.5 Chikungunya
7.7.4.6 Zika Virus
7.7.4.7 and Others
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Medication
7.7.5.2 Vaccination
7.7.5.3 Vector Control Methods
7.7.5.4 Immunotherapy
7.7.5.5 Supportive Care
7.7.5.6 and Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Mosquito Borne Disease Scope:
|
Report Data
|
Mosquito Borne Disease Market
|
|
Mosquito Borne Disease Market Size in 2025
|
USD XX million
|
|
Mosquito Borne Disease CAGR 2025 - 2032
|
XX%
|
|
Mosquito Borne Disease Base Year
|
2024
|
|
Mosquito Borne Disease Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
GlaxoSmithKline plc, Sanofi S.A., Pfizer Inc., Merck & Co. Inc., Novartis AG, Johnson & Johnson, Eisai Co. Ltd, Takeda Pharmaceuticals, AstraZeneca, Valeant Pharmaceuticals, Mitsubishi Tanabe Pharma, Abbott, F. Hoffmann-La Roche Ltd, Sun Pharmaceutical Industries Ltd, Lupin Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Serum Institute of India Pvt. Ltd., CSL Limited, Teva Pharmaceutical Industries Ltd.
|
|
Key Segments
|
By Type
Malaria
Dengue
Yellow Fever
West Nile Virus
Chikungunya
Zika Virus
and Others
By Applications
Medication
Vaccination
Vector Control Methods
Immunotherapy
Supportive Care
and Others
|
